Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Novo Nordisk ( (NVO) ) just unveiled an update.
Novo Nordisk A/S has disclosed information in its Annual Report for the year ended December 31, 2024, in compliance with the Iran Threat Reduction and Syria Human Rights Act of 2012 and the Securities Exchange Act of 1934. This filing, made on February 5, 2025, signifies the company’s adherence to regulatory requirements, potentially influencing its operations and stakeholder perceptions.
More about Novo Nordisk
YTD Price Performance: -5.60%
Average Trading Volume: 7,983,463
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $370.2B
Learn more about NVO stock on TipRanks’ Stock Analysis page.
